{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:34:01Z","timestamp":1784892841194,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Centre for Global Health and Medicine grant","award":["grant number 21A1003"],"award-info":[{"award-number":["grant number 21A1003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1245\/s10434-025-17106-1","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T17:09:24Z","timestamp":1742058564000},"page":"5774-5783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Repeat Diagnostic Laparoscopy After Chemotherapy is Useful in Patient Selection for Conversion to Cytoreductive Surgery for Initially Unresectable Colorectal and Appendiceal Peritoneal Metastases: A Retrospective Cohort Study"],"prefix":"10.1245","volume":"32","author":[{"given":"Yoshimasa","family":"Gohda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5202-1239","authenticated-orcid":false,"given":"Hideaki","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichiro","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Mirnezami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyoshi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Kokudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"key":"17106_CR1","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database. Lancet Oncol. 2016;17:1709\u201319.","journal-title":"Lancet Oncol."},{"key":"17106_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263\u20137.","journal-title":"J Clin Oncol."},{"key":"17106_CR3","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","volume":"22","author":"O Glehen","year":"2004","unstructured":"Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284\u201392.","journal-title":"J Clin Oncol."},{"key":"17106_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681\u20135.","journal-title":"J Clin Oncol."},{"key":"17106_CR5","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol."},{"key":"17106_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res."},{"key":"17106_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ejso.2006.03.002","volume":"32","author":"FN Gilly","year":"2006","unstructured":"Gilly FN, Cotte E, Brigand C, et al. Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol. 2006;32:597\u2013601.","journal-title":"Eur J Surg Oncol."},{"key":"17106_CR8","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1245\/s10434-016-5698-x","volume":"24","author":"C Ihemelandu","year":"2017","unstructured":"Ihemelandu C, Sugarbaker PH. Management for peritoneal metastasis of colonic origin: role of cytoreductive surgery and perioperative intraperitoneal chemotherapy: a single institution\u2019s experience during two decades. Ann Surg Oncol. 2017;24:898\u2013905.","journal-title":"Ann Surg Oncol."},{"key":"17106_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/bjs5.50179","volume":"3","author":"S Hallam","year":"2019","unstructured":"Hallam S, Tyler R, Price M, Beggs A, Youssef H. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. BJS Open. 2019;3:585\u201394.","journal-title":"BJS Open."},{"key":"17106_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","volume":"16","author":"JL Koh","year":"2009","unstructured":"Koh JL, Yan TD, Glenn D, Morris DL. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2009;16:327\u201333.","journal-title":"Ann Surg Oncol."},{"key":"17106_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/jso.21601","volume":"102","author":"J Esquivel","year":"2010","unstructured":"Esquivel J, Chua TC, Stojadinovic AJ, et al. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol. 2010;102:565\u201370.","journal-title":"J Surg Oncol."},{"key":"17106_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00261-007-9211-7","volume":"33","author":"C Dromain","year":"2008","unstructured":"Dromain C, Leboulleux S, Auperin A, et al. Staging of peritoneal carcinomatosis: enhanced CT vs. PET\/CT. Abdom Imaging. 2008;33:87\u201393.","journal-title":"Abdom Imaging."},{"key":"17106_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00261-008-9405-7","volume":"34","author":"AM De Gaetano","year":"2009","unstructured":"De Gaetano AM, Calcagni ML, Rufini V, Valenza V, Giordano A, Bonomo L. Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples, and pitfalls. Abdom Imaging. 2009;34:391\u2013402.","journal-title":"Abdom Imaging."},{"key":"17106_CR14","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1007\/s00464-019-06984-8","volume":"34","author":"H Najah","year":"2020","unstructured":"Najah H, Malgras B, Dohan A, Gronnier C, Eveno C, Pocard M. The role of single-incision laparoscopic peritoneal exploration in the management of patients with peritoneal metastases. Surg Endosc. 2020;34:2040\u20139.","journal-title":"Surg Endosc."},{"key":"17106_CR15","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1245\/s10434-015-4958-5","volume":"23","author":"RA Marmor","year":"2016","unstructured":"Marmor RA, Kelly KJ, Lowy AM, Baumgartner JM. Laparoscopy is safe and accurate to evaluate peritoneal surface metastasis prior to cytoreductive surgery. Ann Surg Oncol. 2016;23:1461\u20137.","journal-title":"Ann Surg Oncol."},{"key":"17106_CR16","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/jso.23924","volume":"111","author":"P Tabrizian","year":"2015","unstructured":"Tabrizian P, Jayakrishnan TT, Zacharias A, et al. Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: a multi-institutional analysis. J Surg Oncol. 2015;111:1035\u201340.","journal-title":"J Surg Oncol."},{"key":"17106_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1477-7819-12-270","volume":"12","author":"TT Jayakrishnan","year":"2014","unstructured":"Jayakrishnan TT, Zacharias AJ, Sharma A, Pappas SG, Gamblin TC, Turaga KK. Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). World J Surg Oncol. 2014;12:270.","journal-title":"World J Surg Oncol."},{"key":"17106_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/bjs.8908","volume":"100","author":"LH Iversen","year":"2013","unstructured":"Iversen LH, Rasmussen PC, Laurberg S. Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg. 2013;100:285\u201392.","journal-title":"Br J Surg."},{"key":"17106_CR19","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1007\/s11605-019-04368-w","volume":"24","author":"F Carboni","year":"2020","unstructured":"Carboni F, Federici O, Giofr\u00e8 M, Valle M. An 18-year experience in diagnostic laparoscopy of peritoneal carcinomatosis: results from 744 patients. J Gastrointest Surg. 2020;24:2096\u2013103.","journal-title":"J Gastrointest Surg."},{"key":"17106_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.suronc.2020.02.010","volume":"33","author":"M Leimk\u00fchler","year":"2020","unstructured":"Leimk\u00fchler M, de Haas RJ, Pol VEH, et al. Adding diagnostic laparoscopy to computed tomography for the evaluation of peritoneal metastases in patients with colorectal cancer: a retrospective cohort study. Surg Oncol. 2020;33:135\u201340.","journal-title":"Surg Oncol."},{"key":"17106_CR21","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1245\/s10434-019-07957-w","volume":"27","author":"JEKR Hentzen","year":"2020","unstructured":"Hentzen JEKR, Constansia RDN, Been LB, et al. Diagnostic laparoscopy as a selection tool for patients with colorectal peritoneal metastases to prevent a non-therapeutic laparotomy during cytoreductive surgery. Ann Surg Oncol. 2020;27:1084\u201393.","journal-title":"Ann Surg Oncol."},{"key":"17106_CR22","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1007\/s00464-017-5923-0","volume":"32","author":"P von Breitenbuch","year":"2018","unstructured":"von Breitenbuch P, Boerner T, Jeiter T, Piso P, Schlitt HJ. Laparoscopy as a useful selection tool for patients with prior surgery and peritoneal metastases suitable for multimodality treatment strategies. Surg Endosc. 2018;32:2288\u201394.","journal-title":"Surg Endosc."},{"key":"17106_CR23","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1200\/JCO.2006.07.2546","volume":"24","author":"L Leichman","year":"2006","unstructured":"Leichman L. Neoadjuvant chemotherapy for disseminated colorectal cancer: changing the paradigm. J Clin Oncol. 2006;24:3817\u20138.","journal-title":"J Clin Oncol."},{"key":"17106_CR24","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","volume":"14","author":"B Nordlinger","year":"2013","unstructured":"Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Australasian gastro-intestinal trials group (AGITG) and f\u00e9d\u00e9ration francophone de canc\u00e9rologie digestive (FFCD). Lancet Oncol. 2013;14:1208\u201315.","journal-title":"Lancet Oncol."},{"key":"17106_CR25","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1200\/JCO.21.01032","volume":"39","author":"Y Kanemitsu","year":"2021","unstructured":"Kanemitsu Y, Shimizu Y, Mizusawa J, et al. Hepatectomy followed by mFOLFOX6 versus hepatectomy alone for liver-only metastatic colorectal cancer (JCOG0603): a phase II or III randomized controlled trial. J Clin Oncol. 2021;39:3789\u201399.","journal-title":"J Clin Oncol."},{"key":"17106_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S1470-2045(09)70330-4","volume":"11","author":"G Folprecht","year":"2010","unstructured":"Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol. 2010;11:38\u201347.","journal-title":"Lancet Oncol."},{"key":"17106_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/annonc\/mdi092","volume":"16","author":"T Delaunoit","year":"2005","unstructured":"Delaunoit T, Alberts SR, Sargent DJ, et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol. 2005;16:425\u20139.","journal-title":"Ann Oncol."},{"key":"17106_CR28","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.3748\/wjg.v16.i26.3318","volume":"16","author":"WH Li","year":"2010","unstructured":"Li WH, Peng JJ, Xiang JQ, Chen W, Cai SJ, Zhang W. Oncological outcome of unresectable lung metastases without extrapulmonary metastases in colorectal cancer. World J Gastroenterol. 2010;16:3318\u201324.","journal-title":"World J Gastroenterol."},{"key":"17106_CR29","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.7150\/jca.53824","volume":"12","author":"T Liu","year":"2021","unstructured":"Liu T, Chang W, Wang J, et al. Efficacy of conversion therapy on initially unresectable locally advanced rectal cancer. J Cancer. 2021;12:4418\u201323.","journal-title":"J Cancer."},{"key":"17106_CR30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/codi.12560","volume":"16","author":"D Hompes","year":"2014","unstructured":"Hompes D, Aalbers A, Boot H, et al. A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer. Colorectal Dis. 2014;16:264\u201372.","journal-title":"Colorectal Dis."},{"key":"17106_CR31","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/bjs\/znad228","volume":"110","author":"RAG van Eerden","year":"2023","unstructured":"van Eerden RAG, de Boer NL, van Kooten JP, et al. Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases. Br J Surg. 2023;110:1502\u201310.","journal-title":"Br J Surg."},{"key":"17106_CR32","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s11605-018-3983-7","volume":"23","author":"M Nakamura","year":"2019","unstructured":"Nakamura M, Ojima T, Nakamori M, et al. Conversion surgery for gastric cancer with peritoneal metastasis based on the diagnosis of second-look staging laparoscopy. J Gastrointest Surg. 2019;23:1758\u201366.","journal-title":"J Gastrointest Surg."},{"key":"17106_CR33","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00464-008-0324-z","volume":"23","author":"K Inoue","year":"2009","unstructured":"Inoue K, Nakane Y, Michiura T, et al. Feasibility and accuracy of second-look laparoscopy after gastrectomy for gastric cancer. Surg Endosc. 2009;23:2307\u201313.","journal-title":"Surg Endosc."},{"key":"17106_CR34","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1245\/s10434-012-2598-6","volume":"20","author":"K Cardona","year":"2013","unstructured":"Cardona K, Zhou Q, G\u00f6nen M, et al. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Ann Surg Oncol. 2013;20:548\u201354.","journal-title":"Ann Surg Oncol."},{"key":"17106_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jso.25094","volume":"118","author":"CA Thiels","year":"2018","unstructured":"Thiels CA, Ikoma N, Fournier K, et al. Repeat staging laparoscopy for gastric cancer after preoperative therapy. J Surg Oncol. 2018;118:61\u20137.","journal-title":"J Surg Oncol."},{"key":"17106_CR36","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/bjs.10527","volume":"104","author":"A Dohan","year":"2017","unstructured":"Dohan A, Hoeffel C, Soyer P, et al. Evaluation of the peritoneal carcinomatosis index with CT and MRI. Br J Surg. 2017;104:1244\u20139.","journal-title":"Br J Surg."},{"key":"17106_CR37","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s00330-019-06524-x","volume":"30","author":"I Van\u2019t Sant","year":"2020","unstructured":"Van\u2019t Sant I, Engbersen MP, Bhairosing PA, et al. Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis. Eur Radiol. 2020;30:3101\u201312.","journal-title":"Eur Radiol."},{"key":"17106_CR38","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ejso.2021.09.014","volume":"48","author":"I Van\u2019t Sant","year":"2022","unstructured":"Van\u2019t Sant I, Nerad E, Rijsemus CJV, et al. Seeing the whole picture: added value of MRI for extraperitoneal findings in CRS-HIPEC candidates. Eur J Surg Oncol. 2022;48:462\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"17106_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40644-018-0187-z","volume":"19","author":"RC Dresen","year":"2019","unstructured":"Dresen RC, De Vuysere S, De Keyzer F, et al. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases. Cancer Imaging. 2019;19:1.","journal-title":"Cancer Imaging."},{"key":"17106_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:256\u201366.","journal-title":"Lancet Oncol."},{"key":"17106_CR41","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","volume":"20","author":"M Alyami","year":"2019","unstructured":"Alyami M, H\u00fcbner M, Grass F, et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019;20:e368\u201377.","journal-title":"Lancet Oncol."},{"key":"17106_CR42","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.ejso.2016.03.016","volume":"42","author":"Y Yonemura","year":"2016","unstructured":"Yonemura Y, Canbay E, Li Y, et al. A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. Eur J Surg Oncol. 2016;42:1123\u201331.","journal-title":"Eur J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17106-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17106-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:54:55Z","timestamp":1751464495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17106-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["17106"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17106-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}